Welcome!
Hyphens Pharma
Broker's Calls
Broker's Digest: Guocoland, Yangzijiang Shipbuilding, Keppel Corp, HRNetGroup, Hyphens Pharma International
Broker's Digest: Guocoland, Yangzijiang Shipbuilding, Keppel Corp, HRNetGroup, Hyphens Pharma International
April 07, 2022
Broker's Calls
Analysts positive on Hyphens Pharma with Novem acquisition to boost growth
Analysts positive on Hyphens Pharma with Novem acquisition to boost growth
April 06, 2022
Healthcare
Hyphens Pharma launches WellAway, Singapore’s first HSA-registered e-pharmacy
Hyphens Pharma officially launches WellAway, Singapore’s first HSA-registered e-pharmacy
January 10, 2022
Broker's Calls
Hyphens Pharma's growth mindset catches the eye of CGS-CIMB
CGS-CIMB is initiating coverage on Hyphens Pharma with an ‘add’ call and target price of 36 cents.
January 07, 2022
Contracts
Hyphens Pharma signs exclusive licensing deal of Ustekinumab biosimilar for Singapore, Malaysia and the Philippines
The exclusive license and supply agreement will not have a material effect on the group’s NTA or EPS for FY2021.
December 14, 2021
Broker's Calls
Hyphens Pharma 9M21 PATMI exceeds expectations amidst speed bump in Vietnam: PhillipCapital
For the 9MFY2021 ended September, Hyphens Pharma reported PATMI of $1.09 million, 28.8% higher y-o-y
November 25, 2021
Broker's Calls
Hyphens Pharma gets a 'buy' from SAC as it looks to undertake more R&D initiatives
SAC Capital is maintaining its “buy” call and target price of 37 cents on pharmaceutical distributor Hyphens Pharma.
August 27, 2021
Broker's Calls
Broker's Digest: China Aviation Oil, Hyphens Pharma, UG Healthcare, BHG Retail
See the analysts' recommendations and target prices here.
July 02, 2021
Broker's Calls
A promising 1Q2021 performance sees KGI upgrading Hyphens Pharma to 'outperform'
The analysts have upgraded their call on the group from “neutral” to “outperform”, at a revised target price of 43 cents.
June 28, 2021
Positioning for the recovery
PhillipCapital eyes year-end STI at 3,200
“Investors are positioning ahead of the expected normality to pre-Covid-19 economic conditions," says PhillipCapital.
December 24, 2020